Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Júlia Aliz Baán"'
Autor:
Tamas Kocsis, Luca Mendler, Kitti Szabo, László Dux, Aniko Keller-Pinter, György Trencsényi, Hans Reinauer, Júlia Aliz Baán, Géza Müller, Ildikó Garai, Ferenc Deák
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 312:E150-E160
The TGFβ family member myostatin (growth/differentiation factor-8) is a negative regulator of skeletal muscle growth. The hypermuscular Compact mice carry the 12-bp Mstn(Cmpt-dl1Abc) deletion in the sequence encoding the propeptide region of the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bba2ee4e061aeaf58ce2391cedf3afb9
https://doi.org/10.1152/ajpendo.00216.2016
https://doi.org/10.1152/ajpendo.00216.2016
Autor:
László G. Puskás, Gergely Ágoston, Péter Ferdinandy, Nóra Faragó, Gábor Jancsó, Bence Ágg, Péter Sántha, Albert Varga, Krisztina Kiss, Kamilla Gömöri, Péter Bencsik, Ágnes Zvara, Luca Mendler, Júlia Aliz Baán
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 4, p 991 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 4
International Journal of Molecular Sciences
Volume 20
Issue 4
Background: Here we examined myocardial microRNA (miRNA) expression profile in a sensory neuropathy model with cardiac diastolic dysfunction and aimed to identify key mRNA molecular targets of the differentially expressed miRNAs that may contribute t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d7c4361e626f2e22b3bb4e4752c715c
https://www.mdpi.com/1422-0067/20/4/991
https://www.mdpi.com/1422-0067/20/4/991
Autor:
Luca Mendler, Przemysław Leszek, Júlia Aliz Baán, László Dux, Tamás Baranyai, Péter Ferdinandy, Mariusz Kuśmierczyk, Thomas Braun, Zoltán Varga
Publikováno v:
Journal of Translational Medicine
Background Myostatin (Mstn) is a key regulator of heart metabolism and cardiomyocyte growth interacting tightly with insulin-like growth factor I (IGF-I) under physiological conditions. The pathological role of Mstn has also been suggested since Mstn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5da5ebf3d3bdc6b149263ef0fec4070
http://europepmc.org/articles/PMC4301667
http://europepmc.org/articles/PMC4301667
Publikováno v:
European Journal of Histochemistry, Vol 58, Iss 3 (2014)
European Journal of Histochemistry : EJH
European Journal of Histochemistry : EJH
The TGF-beta member myostatin acts as a negative regulator of skeletal muscle mass. The Compact mice were selected for high protein content and hypermuscularity, and carry a naturally occurring 12-bp deletion in the propeptide region of the myostatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a15be6e1d2923fcb7977395602c64c1
https://doi.org/10.4081/ejh.2014.2353
https://doi.org/10.4081/ejh.2014.2353
Autor:
Júlia Aliz Baán, László Dux, Géza Müller, Ernö Zádor, Tamas Kocsis, Luca Mendler, Aniko Keller-Pinter
Publikováno v:
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 61(12)
Myostatin is an important negative regulator of skeletal muscle growth. The hypermuscular Compact ( Cmpt) mice carry a 12-bp natural mutation in the myostatin propeptide, with additional modifier genes being responsible for the phenotype. Muscle cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86ec7bd203f1c7dafca92285a83dbed9
https://pubmed.ncbi.nlm.nih.gov/23979839
https://pubmed.ncbi.nlm.nih.gov/23979839
Publikováno v:
Neuromuscular Disorders. 24:875
The TGF-beta member myostatin is an important negative regulator of skeletal muscle mass, influencing systemic (e.g. carbohydrate) metabolism. Beyond the Smad2/3 mediated signaling events it regulates the PI3K/Akt pathway, which plays a central role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::247cfe8473be6450e6c0d2d0df5bcab8
https://doi.org/10.1016/j.nmd.2014.06.272
https://doi.org/10.1016/j.nmd.2014.06.272
Autor:
Baán, Júlia Aliz1 baan.julia@med.u-szeged.hu, Varga, Zoltán V.2 varga.zoltan@med.semmelweis-univ.hu, Leszek, Przemyslaw3 przemyslaw.leszek@ikard.pl, Kuśmierczyk, Mariusz3 mkusmierczyk@ikard.pl, Baranyai, Tamás2 baranyai.tamas@med.semmelweis-univ.hu, Dux, László1 dux.laszlo@med.u-szeged.hu, Ferdinandy, Péter2,4 peter.ferdinandy@pharmahungary.com, Braun, Thomas5 thomas.braun@mpi-bn.mpg.de, Mendler, Luca1,6 mendler.luca@med.u-szeged.hu
Publikováno v:
Journal of Translational Medicine. 2015, Vol. 13 Issue 1, p201-218. 18p.